Otros idiomas Guangzhou Wondfo Biotech Co.,Ltd

Acciones

300482

CNE100002102

Precio de cierre Shenzhen S.E. Otros sitios de cotización 00:00:00 30/04/2024			Varia. Cinco días.	Varia. 1 de enero.
27,67 ^CNY	+3,79 %		+3,63 %	-8,29 %

21/04	Guangzhou Wondfo Biotech Co.,Ltd presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
2023	Guangzhou Wondfo Biotech Co.,Ltd comunica los resultados de los nueve meses finalizados el 30 de septiembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	21/04
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	15/08/23
Tranche Update on Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback Plan announced on July 5, 2023.	12/07/23
Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback announced on July 5, 2023 has closed with 1,121,900 shares, representing 0.25% for CNY 30.1 million.	11/07/23
Guangzhou Wondfo Biotech Co.,Ltd announces an Equity Buyback for CNY 50 million worth of its shares.	05/07/23
Guangzhou Wondfo Biotech Co.,Ltd authorizes a Buyback Plan.	05/07/23
Beijing PolySeq Technology Co., Ltd. announced that it has received CNY 100 million in funding from Guangzhou Wondfo Biotech Co.,Ltd, Guangzhou Sanmei Investment Management Center (Limited Partnership), Shangshi Capital, IDG Capital Partners Co., Ltd., Tsinghua Innovation Ventures	12/05/23
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23
Guangzhou Wondfo Biotech Co.,Ltd Approves the Cash Dividend for the Year 2022, Payable on 18 May 2023	24/04/23
Announcement on Resolutions of the 2022 Annual General Meeting of Guangzhou Wondfo Biotech	21/04/23
Guangzhou Huiyin Tianyue Nominates Mr.Ge Xinhua as Supervisor	10/04/23
Guangzhou Wondfo Biotech Co.,Ltd Proposes Final Cash Dividend for the Year 2022	31/03/23
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23
Beijing PolySeq Technology Co., Ltd. announced that it expects to receive CNY 40 million in funding from Guangzhou Wondfo Biotech Co.,Ltd, Guangzhou Sanmei Investment Management Center (Limited Partnership), Shangshi Capital, IDG Capital Partners Co., Ltd., Tsinghua Innovation Ventures	20/03/23
Investors bet on greed and fear as China loosens COVID grip	09/12/22
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22
Tranche Update on Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback Plan announced on September 26, 2022.	12/10/22
Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback announced on September 26, 2022, has expired with 1,046,200 shares, representing 0.24% for CNY 30.10 million.	11/10/22
Guangzhou Wondfo Biotech Co.,Ltd announces an Equity Buyback for CNY 50 million worth of its shares.	26/09/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Guangzhou Wondfo Biotech Co.,Ltd

Acciones

300482

CNE100002102

Otros idiomas

Filtros